Wormwood
9 benefits mapped to clinical evidence across supplements.
Dose per serving from products
187 products in our catalogue print how much Wormwood a serving holds.
Most common: 50 mg to 100 mg, 34% of 187 products.
| Dose per serving | Products |
|---|---|
| 25 mg or less | 5 |
| 25 mg to 50 mg | 21 |
| 50 mg to 100 mg | 63 |
| 100 mg to 250 mg | 20 |
| 250 mg to 500 mg | 58 |
| 500 mg to 1 g | 10 |
| 1 g to 2.5 g | 10 |
Dose per serving from research
8 study groups in 7 studies say how much Wormwood participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 100 mg to 250 mg, 63% of 8 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mg to 250 mg | 5 |
| 250 mg to 500 mg | 0 |
| 500 mg to 1 g | 0 |
| 1 g to 2.5 g | 3 |
Benefit Evidence
Digestion symptoms + relief
+44.7% IBS-D relief
Crohnâs remission, â67% TNF-α
Inflammation down: CRP/ESR
TNF-α â67%, joints/remission
Pain/function improved
Digestion symptoms + relief
+44.7% IBS-D relief
Crohnâs remission, â67% TNF-α
Inflammation down: CRP/ESR
TNF-α â67%, joints/remission
Pain/function improved
Research sources
Antimicrobial (9)
- Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area
PubMed ID: 21827706
Artemisininâbased combos yielded high 28âday cure rates for multidrugâresistant falciparum malaria (large clinical trial).
- Comparison of the anticoccidial effect of granulated extract of Artemisia sieberi with monensin in experimental coccidiosis in broiler chickens
PubMed ID: 24703975
Granulated Artemisia sieberi reduced Eimeria OPG and improved performance in broilers â strong antiparasitic animal evidence comparable to monensin.
- Prophylactic and therapeutic effects of a novel granulated formulation of Artemisia extract on broiler coccidiosis
PubMed ID: 23868546
Granulated Artemisia sieberi decreased mortality, lesions and oocyst output in experimentally infected broilers (robust animal antiparasitic evidence).
- Use of Artemisia annua as a natural coccidiostat in free-range broilers and its effects on infection dynamics and performance
PubMed ID: 22154969
Field broiler supplementation lowered Eimeria oocyst shedding (meaningful antiparasitic effect in animals).
- Effects of Artemisia annua and Foeniculum vulgare on chickens highly infected with Eimeria tenella (phylum Apicomplexa)
PubMed ID: 24731599
A. annua leaf powder dramatically reduced gut parasite burden and oocyst output in broiler chickens (strong antiparasitic animal data).
- Anticoccidial effects of Artemisia annua ethanolic extract: prevention, simultaneous challenge-medication, and treatment
PubMed ID: 28766151
Preventive use of Artemisia annua extract in chicks reduced coccidial oocyst counts and improved weight gain (clear anticoccidial/parasite control in animals).
- Artemisia annua and Artemisia afra tea infusions vs. artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trial
PubMed ID: 30668322
Large randomized clinical trial: Artemisia annua/afra teas produced very high cure rates and faster parasite/fever clearance in uncomplicated malaria (definitive antiparasitic effect in humans).
- Effect of Artemisia annua and Artemisia afra tea infusions on schistosomiasis in a large clinical trial
PubMed ID: 30466622
Randomized clinical trial: Artemisia teas achieved faster and complete egg clearance in schistosomiasis versus praziquantel (robust human antiparasitic evidence).
- Open-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malaria
PubMed ID: 18320064
Artemisinin derivatives produced rapid parasite clearance and gametocyte suppression in falciparum malaria (very strong antiparasitic human evidence in combination regimens).
Immune support (7)
- Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study
PubMed ID: 17240130
Strong clinical effects in Crohn's including steroid-sparing remission; implies immunomodulatory activity of the wormwood-containing formula.
- Artemisia annua-sublingual immunotherapy for seasonal allergic rhinitis: A randomized controlled trial
PubMed ID: 32030780
Phase III sublingual Artemisia annua immunotherapy reduced nasal symptoms and shifted Tâcell profiles toward regulatory phenotypes (direct immunomodulation).
- Clinical Efficacy and Safety of Artesimia annua-Sublingual Immunotherapy in Seasonal Allergic Rhinitis Patients Based on Different Intervention Time
PubMed ID: 35413714
Preseasonal Artemisia annua SLIT improved symptoms and had immunologic relevance in allergic rhinitis (clinically meaningful immunotherapy effect).
- Clinical efficacy in one-year treatment with Artemisia annua-SLIT drops in monosensitized and polysensitized individuals
PubMed ID: 37478537
Oneâyear Artemisia annua SLIT produced sustained reductions in rhinoconjunctivitis symptoms and medication use (robust allergenâspecific immune benefit).
- Evaluation of the effects of Artemisia Annua L. and Moringa Oleifera Lam. on CD4 count and viral load among PLWH on ART at Mbarara Regional Referral Hospital: a double-blind randomized controlled clinical trial
PubMed ID: 38627722
Large RCT in PLWH on ART: Artemisia supplementation (±Moringa) markedly increased CD4 counts and improved viral suppression (strong immunologic benefit).
- Coseasonal initiation of Artemisia annua sublingual immunotherapy in children and adult patients with allergic rhinoconjunctivitis
PubMed ID: 39611955
One-year Artemisia annua sublingual immunotherapy significantly reduced allergic rhinoconjunctivitis symptoms and medication use (immune modulation).
- The effect of acupuncture on allergic rhinitis: a randomized controlled clinical trial
PubMed ID: 15154290
Acupuncture trial showed reductions in mugwort-specific IgE and skin test reactivity (immunologic changes related to mugwort).
Digestive support (4)
- Mild moxibustion for Irritable Bowel Syndrome with Diarrhea (IBS-D): A randomized controlled trial
PubMed ID: 35114338
Wellâconducted RCT of mild moxibustion (Artemisia) produced large, clinically meaningful symptom relief in IBSâD (direct digestive symptom benefit).
- Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority Study
PubMed ID: 28960033
Large RCT showing Artemisia asiatica formulation is nonâinferior for erosive gastritis (objective endoscopic improvement â direct digestive benefit).
- Efficacy of DA-5204 (Stillen 2X) for patients with gastroesophageal reflux disease: A randomized, double-blind, placebo-controlled pilot study
PubMed ID: 33126310
Pilot RCT adding Artemisia asiatica tablet to PPI reduced residual minimalâchange mucosal lesions in esophagitis (improved mucosal findings â digestive comfort).
- Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study
PubMed ID: 17240130
Wormwood-containing treatment produced clinical remission and steroid-sparing in Crohn's disease, indicating improved GI symptoms/comfort.
Inflammation (4)
- Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study
PubMed ID: 17240130
Wormwood-containing herbal allowed steroid tapering and clinical remission in Crohn's, indicating potent anti-inflammatory/immune effects.
- A pilot randomized, placebo-controlled clinical trial to investigate the efficacy and safety of an extract of Artemisia annua administered over 12Â weeks, for managing pain, stiffness, and functional limitation associated with osteoarthritis of the hip and knee
PubMed ID: 26631103
OA pain/function improvements in RCT may reflect anti-inflammatory effects of Artemisia extract (plausible mechanism).
- Effect of Artemisia annua extract on treating active rheumatoid arthritis: A randomized controlled trial
PubMed ID: 28035541
RA RCT showed reductions in CRP/ESR and joint counts when Artemisia annua extract was added to standard therapy (clear antiâinflammatory clinical signals).
- An open-label six-month extension study to investigate the safety and efficacy of an extract of Artemisia annua for managing pain, stiffness and functional limitation associated with osteoarthritis of the hip and knee
PubMed ID: 27806033
Sustained reductions in osteoarthritis pain/stiffness in openâlabel extension suggest anti-inflammatory or analgesic activity.
Joint comfort (3)
- An open-label six-month extension study to investigate the safety and efficacy of an extract of Artemisia annua for managing pain, stiffness and functional limitation associated with osteoarthritis of the hip and knee
PubMed ID: 27806033
Openâlabel extension showed sustained reductions in osteoarthritis pain/stiffness with Artemisia annua extract (supportive but uncontrolled/small).
- A pilot randomized, placebo-controlled clinical trial to investigate the efficacy and safety of an extract of Artemisia annua administered over 12Â weeks, for managing pain, stiffness, and functional limitation associated with osteoarthritis of the hip and knee
PubMed ID: 26631103
Randomized 12âweek RCT: lowâdose Artemisia annua extract reduced hip/knee OA pain (WOMAC, VAS) vs placebo.
- Effect of Artemisia annua extract on treating active rheumatoid arthritis: A randomized controlled trial
PubMed ID: 28035541
Randomized trial in active rheumatoid arthritis: Artemisia annua extract added to standard therapy improved pain, swollen/painful joint counts and inflammatory markers (direct joint symptom benefit).
Antioxidant (1)
- Effect of dietary supplementation of Lactobacillus-fermented Artemisia princeps on growth performance, meat lipid peroxidation, and intestinal microflora in Hy-line Brown male chickens
PubMed ID: 23091141
Reduced meat lipid peroxidation (TBARS) in broilers fed fermented Artemisia, indicating antioxidant activity.
Bloating & gas (1)
- Mild moxibustion for Irritable Bowel Syndrome with Diarrhea (IBS-D): A randomized controlled trial
PubMed ID: 35114338
Mild moxibustion (Artemisia) showed large symptom relief in IBSâD where bloating is a common symptom (direct digestive/bloating benefit).
Appetite regulation (1)
- Effects of Artemisia supplementation on anorexia in hemodialysis patients: a randomized, double-blind placebo-controlled trial
PubMed ID: 33583158
Randomized doubleâblind placeboâcontrolled trial in hemodialysis patients: sixâweek Artemisia supplementation improved reported appetite (direct, clinically measured outcome).
Mental clarity (1)
- Disgust evoked by strong wormwood bitterness influences the processing of visual food cues in women: An ERP study
PubMed ID: 27664457
Small human experimental study: a wormwood bitter mouth rinse increased early EEG attention potentials (N100/N200), indicating an acute attentional/alerting effect.
Similar by evidence
Supplements the same benefits carry qualifying findings for â a fact about the evidence graph, not a recommendation to swap.
Products with Wormwood
Search all392 products whose verified label declares Wormwood â not every bottle that mentions it in a title.
Being studied right now
Recruiting clinical trials registered on ClinicalTrials.gov. A trial in progress has no result yet â this is what the field is asking, not what it found.